A supplement to Internal Medicine News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.
- Introduction
- Prevalence and Etiology
- Signs and Symptoms
- Disease Progression
- Shortcomings of Available Palliative Prescription Therapies
- Role of Metanx® in Diabetic Neuropathy
- A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
- Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats
Faculty/Faculty Disclosures
Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia
Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.
Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana
Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.